Stock listing

Crossject Sa

Selected listing: ALCJ · EURONEXT · EUR · FR

Crossject Sa (Euronext:ALCJ), Health Technology. Latest release Sep 25, 2026: CROSSJECT structure sa gouvernance pour la phase de déploiement industriel et…

ALCJ:EURONEXTEURFRUpdated October 2, 2026

Ticker: Euronext:ALCJ
Asset type: Stock
Sector: Health Technology
Industry: Medical Specialties
Exchange: Euronext
Currency: EUR

About Crossject Sa

Crossject SA is a public company listed under the ticker ALCJ on the French market. Crossject focuses on developing innovative drug delivery systems, aiming to enhance patient care and treatment efficiency.

Latest news from Crossject Sa

CROSSJECT structure sa gouvernance pour la phase de déploiement industriel et commercial

September 24, 2026

CROSSJECT strengthens its governance for the industrial and commercial deployment phase

September 24, 2026

CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure

September 24, 2026

CROSSJECT publie ses résultats du premier semestre 2026 et présente une structure financière profondément renforcée

September 24, 2026

CROSSJECT Reports Its First-Half 2026 Results and Presents a Significantly Strengthened Financial Structure

September 25, 2026

All Crossject Sa news →

Research Crossject Sa

Crossject Sa company profile

View the public company page for Crossject Sa on 6ix.

Crossject Sa news

Read company news and market updates connected to Crossject Sa.

Crossject Sa investor events

Find investor webinars, events, and replay context for Crossject Sa.